MD Magazine: Specialty: Endocrinology Copyright (c) 2017 Intellisphere, LLC. All rights reserved. http://www.mdmag.com/specialty/endocrinology/rss Endocrinology en-us Wed, 19 Jun 2019 00:07:15 UTC Switching to Insulin Glargine Plus Lixisenatide from GLP-1RA http://www.mdmag.com/medical-news/switching-to-insulin-glargine-plus-lixisenatide-from-glp1ra Tue, 18 Jun 2019 17:00:00 UTC Sam Engel, MD: Sitagliptin versus Dapagliflozin in Older Patients http://www.mdmag.com/conference-coverage/ada-2019/sam-engel-md-sitagliptin-versus-dapagliflozin-in-older-patients Tue, 18 Jun 2019 13:00:00 UTC Meg Jardine, MBBS: Results and Impact of CREDENCE Results http://www.mdmag.com/conference-coverage/ada-2019/results-and-impact-of-credence-results Tue, 18 Jun 2019 13:00:00 UTC FDA Approves Liraglutide for Pediatric Patients with Type 2 Diabetes http://www.mdmag.com/medical-news/fda-approves-liraglutide-for-pediatric-patients-with-type-2-diabetes Mon, 17 Jun 2019 21:02:00 UTC Bruce Bode, MD: Hypoglycemic Effect of Hepatic-Directed Insulin http://www.mdmag.com/conference-coverage/ada-2019/bruce-bode-md-hypoglycemic-effect-of-hepatic-directed-insulin Mon, 17 Jun 2019 17:00:00 UTC Sam Engel, MD: Ertugliflozin Two-Year Impact on Renal Function http://www.mdmag.com/conference-coverage/ada-2019/sam-engel-ertugliflozin-two-year-impact-on-renal-function Mon, 17 Jun 2019 14:02:00 UTC Ofri Mosenzon, MD: Dapagliflozin Impact on Renal Outcomes http://www.mdmag.com/conference-coverage/ada-2019/ofri-mosenzon-md-dapagliflozin-impact-on-renal-outcomes Fri, 14 Jun 2019 17:00:00 UTC Cardiovascular Risks Inflict Nearly Half of All Type 1 Diabetes Patients http://www.mdmag.com/conference-coverage/ada-2019/cardiovascular-risks-type-1-diabetes Fri, 14 Jun 2019 15:05:00 UTC Chris Sorli, MD: Renal Function on Toujeo versus Tresiba http://www.mdmag.com/conference-coverage/ada-2019/chris-sorli-md-renal-function-on-toujeo-versus-tresiba Fri, 14 Jun 2019 15:00:00 UTC Patrick Burgess, MD: Biggest Challenges Facing Diabetes Patients http://www.mdmag.com/conference-coverage/ada-2019/patrick-burgess-md-biggest-challenges-facing-diabetes-patients Fri, 14 Jun 2019 13:18:00 UTC Mahmood Kazemi, MD: Effectiveness of FreeStyle Libre for HbA1c Reduction http://www.mdmag.com/conference-coverage/ada-2019/mahmood-kazemi-md-freestyle-libre-for-hba1c-reduction Thu, 13 Jun 2019 19:03:00 UTC Sanjoy Paul, PhD: Depression, Antidepressant Use Among Diabetes Patients http://www.mdmag.com/conference-coverage/ada-2019/sanjoy-paul-phd-depression-antidepressant-use-among-diabetes-patients Thu, 13 Jun 2019 18:00:00 UTC Nicole Handlow: Impact of Multidisciplinary Team on Glycemic Control http://www.mdmag.com/conference-coverage/ada-2019/nicole-handlow-impact-of-multidisciplinary-team-on-glycemic-control Thu, 13 Jun 2019 17:00:00 UTC Teplizumab Halves Type 1 Diabetes Diagnoses in Phase 2 Trial http://www.mdmag.com/conference-coverage/ada-2019/teplizumab-type-1-diabetes-phase-2-trial Tue, 11 Jun 2019 16:36:00 UTC Basal Insulin Has One-Year Window of Benefit Toward Glycemic Control http://www.mdmag.com/conference-coverage/ada-2019/basal-insulin-benefit-glycemic-control Tue, 11 Jun 2019 13:30:00 UTC Trial Compares CV Outcomes in SGLT-2 Inhibitors Versus GLP-1 Agonists http://www.mdmag.com/conference-coverage/ada-2019/cv-outcomes-sglt-2-inhibitors-versus-glp1-agonists Mon, 10 Jun 2019 23:40:00 UTC New FIELD Study Assessment Links HDL Fractions to T2D Cardiovascular Risks http://www.mdmag.com/conference-coverage/ada-2019/field-study-hdl-fractions-t2d-cardiovascular Mon, 10 Jun 2019 21:29:00 UTC Patrick Burgess, MD: Hypoglycemia and Impact of Late Glucose Checks http://www.mdmag.com/conference-coverage/ada-2019/patrick-burgess-md-hypoglycemia-and-impact-of-late-glucose-checks Mon, 10 Jun 2019 17:57:00 UTC Five-Year REWIND Results Show Sustained Dulaglutide CV Benefits http://www.mdmag.com/conference-coverage/ada-2019/five-year-rewind-results-dulaglutide Mon, 10 Jun 2019 07:22:00 UTC Cardiovascular Event Risks Similar in Type 1 & 2 Diabetes Patients http://www.mdmag.com/conference-coverage/ada-2019/cardiovascular-event-risks-type-1-2-diabetes Sun, 09 Jun 2019 23:25:00 UTC John Buse, MD: PIONEER 7 Trial of Oral Semaglutide http://www.mdmag.com/conference-coverage/ada-2019/john-buse-md-pioneer-7-trial-of-oral-semaglutide Sun, 09 Jun 2019 20:39:00 UTC The Evolution of Cardiovascular Care after EMPA-REG http://www.mdmag.com/conference-coverage/ada-2019/evolution-cardiovascular-care-empa-reg Sun, 09 Jun 2019 17:57:00 UTC PREVIEW Data Shows 96% Diabetes Prevention with Diet, Exercise Management http://www.mdmag.com/conference-coverage/ada-2019/preview-data-diabetes-prevention-diet-exercise Sun, 09 Jun 2019 14:59:00 UTC Icosapent Sets New Standard for Macrovascular Disease Prevention http://www.mdmag.com/conference-coverage/ada-2019/icosapent-macrovascular-disease-prevention Sun, 09 Jun 2019 04:57:00 UTC Oral Semaglutide Compared to Liraglutide http://www.mdmag.com/conference-coverage/ada-2019/oral-semaglutide-compared-to-liraglutide Sat, 08 Jun 2019 23:32:00 UTC Oral Semaglutide Compared to Empagliflozin for T2D http://www.mdmag.com/conference-coverage/ada-2019/oral-semaglutide-compared-to-empagliflozin-for-t2d Sat, 08 Jun 2019 17:48:00 UTC ACP Guideline for A1c Levels Provide Cost-Effectiveness for Diabetics http://www.mdmag.com/conference-coverage/ada-2019/acp-guideline-a1c-cost-effectiveness-diabetics Sat, 08 Jun 2019 16:05:00 UTC Vitamin D Supplements Do Not Significantly Reduce Diabetes Risk http://www.mdmag.com/conference-coverage/ada-2019/vitamin-d-reduce-diabetes-risk Fri, 07 Jun 2019 19:39:00 UTC After Bariatric Surgery Teens See Improvements in Diabetes, Hypertension http://www.mdmag.com/medical-news/after-bariatric-surgery-teens-improvements-diabetes-hypertension Thu, 16 May 2019 17:14:00 UTC Diabetes Drug Metformin Associated with Reduced AMD Risk http://www.mdmag.com/medical-news/diabetes-drug-metformin-associated-reduced-amd-risk Thu, 16 May 2019 13:00:00 UTC